SAN

96.15

-3.49%↓

EI

244.1

-1.89%↓

SHL.DE

44.49

-4.08%↓

ARGX

520.2

-2.91%↓

FRE

38.02

-4.35%↓

SAN

96.15

-3.49%↓

EI

244.1

-1.89%↓

SHL.DE

44.49

-4.08%↓

ARGX

520.2

-2.91%↓

FRE

38.02

-4.35%↓

SAN

96.15

-3.49%↓

EI

244.1

-1.89%↓

SHL.DE

44.49

-4.08%↓

ARGX

520.2

-2.91%↓

FRE

38.02

-4.35%↓

SAN

96.15

-3.49%↓

EI

244.1

-1.89%↓

SHL.DE

44.49

-4.08%↓

ARGX

520.2

-2.91%↓

FRE

38.02

-4.35%↓

SAN

96.15

-3.49%↓

EI

244.1

-1.89%↓

SHL.DE

44.49

-4.08%↓

ARGX

520.2

-2.91%↓

FRE

38.02

-4.35%↓

Search

Orion Oyj (Class B)

Închisă

52.5 -5.3

Rezumat

Modificarea prețului

24h

Curent

Minim

52.42

Maxim

52.84

Indicatori cheie

By Trading Economics

Venit

-128M

73M

Vânzări

-37M

434M

P/E

Medie Sector

23.345

63.778

EPS

0.52

Randament dividend

2.99

Marjă de profit

16.897

Angajați

3,880

EBITDA

136M

202M

Dividende

By Dow Jones

Randament dividend

Medie Sector

2.99%

2.39%

Statistici piață

By TradingEconomics

Capitalizare de piață

2.1B

7.7B

Deschiderea anterioară

57.8

Închiderea anterioară

52.5

Orion Oyj (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

4 apr. 2025, 22:38 UTC

Acțiuni populare

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

5 apr. 2025, 09:30 UTC

Câștiguri

Elon Musk's Mr. Fix-It Takes Center Stage During a Really Bad Week -- WSJ

5 apr. 2025, 01:00 UTC

Achiziții, Fuziuni, Preluări

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ

5 apr. 2025, 01:00 UTC

Achiziții, Fuziuni, Preluări

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ -2-

4 apr. 2025, 21:53 UTC

Market Talk

Maxeon's Supply Chain Move at Critical Time for Solar Panel Cos -- Market Talk

4 apr. 2025, 21:44 UTC

Top știri
Achiziții, Fuziuni, Preluări

Trump Grants 75-Day Extension to Reach TikTok Deal -- 3rd Update

4 apr. 2025, 21:00 UTC

Top știri

Americans Were Souring on Trump's Economic Plans Even Before Tariff Bloodbath -- WSJ

4 apr. 2025, 20:52 UTC

Market Talk

Peloton Likely to Escape Tariffs Unscathed -- Market Talk

4 apr. 2025, 20:52 UTC

Top știri

Trump Can Cut Teacher-Training Programs For Now, Supreme Court Says -- WSJ

4 apr. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

4 apr. 2025, 20:48 UTC

Top știri

The Score: Nike, Apple, Stellantis and More Stocks That Defined the Week -- WSJ

4 apr. 2025, 20:45 UTC

Top știri

Hiring Defied Expectations in March, With 228,000 New Jobs -- 6th Update

4 apr. 2025, 20:32 UTC

Top știri

Dow Tumbles 2,000 Points, Bonds Rally After China Retaliates Against Trump Tariffs -- WSJ

4 apr. 2025, 20:21 UTC

Top știri

China Hits Back at Trump With Sweeping Tariffs on All U.S. Goods -- Update

4 apr. 2025, 20:00 UTC

Top știri

Republicans March Ahead on Trump's Tax Cuts as Tariffs Kick In -- WSJ

4 apr. 2025, 19:51 UTC

Market Talk

Dollar Recovers While Recession Fears Grip Wall Street -- Market Talk

4 apr. 2025, 19:37 UTC

Top știri

Trump's Team is Getting the Bond Rally It Wanted. But for the Wrong Reasons. -- WSJ

4 apr. 2025, 19:32 UTC

Market Talk

Oil Selloff Continues as China Responds to U.S. Tariffs -- Market Talk

4 apr. 2025, 19:28 UTC

Top știri

U.S. Stocks Fall Further After China Retaliates Against Trump Tariffs -- Update

4 apr. 2025, 19:15 UTC

Market Talk

Costco Gold, Membership Fees Could Help Cushion from Tariff Costs -- Market Talk

4 apr. 2025, 19:12 UTC

Top știri

Powell Warns of Higher Prices, Weaker Growth After Tariff Plan -- 3rd Update

4 apr. 2025, 19:11 UTC

Market Talk

U.S. Natural Gas Falls as Global Selloff Continues -- Market Talk

4 apr. 2025, 19:09 UTC

Market Talk

Mexican Stocks, Peso Tumble as Global Rout Continues -- Market Talk

4 apr. 2025, 19:09 UTC

Top știri

Trump Grants 75-Day Extension to Reach TikTok Deal -- Second Update

4 apr. 2025, 19:00 UTC

Market Talk

Fed Has Limited Options to Counter Tariffs -- Market Talk

4 apr. 2025, 18:53 UTC

Market Talk

Brace for Trump's Tariff Order to Remain in Place for Extended Period -- Market Talk

4 apr. 2025, 18:51 UTC

Market Talk

Morgan Stanley Analysts Outline Paths to Recession -- Market Talk

4 apr. 2025, 18:44 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

4 apr. 2025, 18:44 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 apr. 2025, 18:44 UTC

Market Talk

Tariffs Won't Achieve What Trump Wants, Morgan Stanley Says -- Market Talk

Comparație

Modificare preț

Orion Oyj (Class B) Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Orion Oyj (Class B)

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. It has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; collaboration and option to license agreement with Abilita Therapeutics to develop innovative antibody therapeutics; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.